Mercer Global Advisors
SUPN icon

Mercer Global Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Mercer Global Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$449K Buy
8,678
+436
+5% +$22.2K ﹤0.01% 2065
2025
Q4 		$410K Sell
8,242
-1,006
-11% -$48.9K ﹤0.01% 2006
2025
Q3 		$442K Sell
9,248
-2,426
-21% -$97.7K ﹤0.01% 1830
2025
Q2 		$368K Buy
11,674
+1,560
+15% +$50K ﹤0.01% 1738
2025
Q1 		$331K Sell
10,114
-65
-0.6% -$2.3K ﹤0.01% 1709
2024
Q4 		$368K Sell
10,179
-921
-8% -$32.4K ﹤0.01% 1626
2024
Q3 		$355K Sell
11,100
-293
-3% -$9.14K ﹤0.01% 1534
2024
Q2 		$305K Sell
11,393
-720
-6% -$20.9K ﹤0.01% 1566
2024
Q1 		$413K Buy
12,113
+811
+7% +$24.1K ﹤0.01% 1387
2023
Q4 		$327K Sell
11,302
-46
-0.4% -$1.22K ﹤0.01% 1557
2023
Q3 		$313K Sell
11,348
-136
-1% -$4.14K ﹤0.01% 1510
2023
Q2 		$345K Buy
11,484
+1,068
+10% +$37.4K ﹤0.01% 1428
2023
Q1 		$377K Buy
10,416
+263
+3% +$10.1K ﹤0.01% 1367
2022
Q4 		$362K Sell
10,153
-2,571
-20% -$89.4K ﹤0.01% 1398
2022
Q3 		$431K Buy
12,724
+510
+4% +$16.6K ﹤0.01% 1202
2022
Q2 		$353K Buy
12,214
+32
+0.3% +$917 ﹤0.01% 1344
2022
Q1 		$394K Buy
12,182
+2,342
+24% +$71.8K ﹤0.01% 1362
2021
Q4 		$287K Buy
9,840
+315
+3% +$9.56K ﹤0.01% 1493
2021
Q3 		$254K Sell
9,525
-312
-3% -$8.37K ﹤0.01% 1502
2021
Q2 		$303K Buy
+9,837
New +$302K ﹤0.01% 1384

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mercer Global Advisors's SUPN Position: Q1 2026 in Review

Mercer Global Advisors increased its Supernus Pharmaceuticals (SUPN) stake by 5.3% in Q1 2026, buying an estimated $22.2K and bringing the position to 8,678 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Mercer Global Advisors first reported a position in SUPN in Q2 2021 and has held it in 20 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Mercer Global Advisors held 8,678 shares of Supernus Pharmaceuticals worth $449K as of Q1 2026.
  • Mercer Global Advisors bought 436 Supernus Pharmaceuticals shares in Q1 2026, an estimated $22.2K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2065 holding.
  • Mercer Global Advisors first reported a position in Supernus Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.